Fingerprint
Dive into the research topics of 'Phase III Randomized, placebo-controlled, double-blind trial of celecoxib in addition to standard chemotherapy for advanced non-small-cell lung cancer with cyclooxygenase-2 overexpression: CALGB 30801 (Alliance)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically